Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

Also called NCT02232360

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02232360
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02232360. Randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone
Intervention (Drug)
Rosuvastatin and fenofibrate
Intervention (Drug)
Rosuvastatin alone
Lead sponsor
Gachon University Gil Medical Center (class: other)
Collaborator
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct02232360
Content hash
d033748e87fc853bb2630e5d885bd86b58330396e3258a5acbe811e2d71421f1